NCT00594191View on ClinicalTrials.gov

Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

November 30, 2007

Conditions
CirrhosisPortal Hypertension
Interventions
DRUG

Simvastatin

20 mg/day p.o., increased to 40 mg/day at day 15 if no safety end-point was met

DRUG

Placebo

Placebo with the same characteristics of the drug and at the same dose

Trial Locations (3)

28871

Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid

08036

Hepatic Hemodynamic Laboratory. Liver Unit. Hospital Clinic., Barcelona

Unknown

Servicio de Gastroenterología, Hospital Universitario General Gregorio Marañón, Madrid

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT00594191 - Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension | Biotech Hunter | Biotech Hunter